Cresset Asset Management LLC trimmed its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 36.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,624 shares of the company's stock after selling 2,678 shares during the period. Cresset Asset Management LLC's holdings in Molina Healthcare were worth $1,346,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Wingate Wealth Advisors Inc. purchased a new position in shares of Molina Healthcare during the 4th quarter worth about $52,000. Hurley Capital LLC acquired a new stake in shares of Molina Healthcare during the fourth quarter worth approximately $55,000. EverSource Wealth Advisors LLC grew its position in shares of Molina Healthcare by 81.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after buying an additional 88 shares in the last quarter. Whittier Trust Co. of Nevada Inc. grew its position in shares of Molina Healthcare by 337.0% during the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock worth $58,000 after buying an additional 155 shares in the last quarter. Finally, Harvest Fund Management Co. Ltd boosted its holdings in Molina Healthcare by 895.0% in the fourth quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company's stock worth $58,000 after purchasing an additional 179 shares during the period. 98.50% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
MOH has been the subject of a number of research reports. Stephens reaffirmed an "equal weight" rating and issued a $345.00 price objective on shares of Molina Healthcare in a report on Thursday, February 6th. Barclays raised their target price on Molina Healthcare from $339.00 to $362.00 and gave the company an "equal weight" rating in a research note on Friday, April 25th. Robert W. Baird reiterated a "neutral" rating and issued a $375.00 target price (up from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. UBS Group cut their target price on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a research note on Friday, February 7th. Finally, Baird R W cut Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Nine equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, Molina Healthcare has a consensus rating of "Hold" and a consensus target price of $365.38.
Check Out Our Latest Stock Analysis on Molina Healthcare
Molina Healthcare Trading Up 3.5%
NYSE:MOH traded up $11.05 during mid-day trading on Friday, hitting $325.02. The company had a trading volume of 518,892 shares, compared to its average volume of 688,746. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $365.23. The business's fifty day moving average is $324.07 and its two-hundred day moving average is $308.32. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The firm has a market cap of $17.62 billion, a P/E ratio of 15.91, a P/E/G ratio of 1.06 and a beta of 0.63.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, beating the consensus estimate of $5.96 by $0.12. The firm had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The company's quarterly revenue was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.73 earnings per share. As a group, research analysts expect that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.
Insider Buying and Selling
In other Molina Healthcare news, Director Richard M. Schapiro sold 669 shares of the firm's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total value of $214,414.50. Following the completion of the transaction, the director now directly owns 11,244 shares in the company, valued at $3,603,702. This trade represents a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the sale, the director now directly owns 17,375 shares of the company's stock, valued at approximately $5,235,608.75. The trade was a 5.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 89,169 shares of company stock worth $28,520,995. 1.10% of the stock is owned by corporate insiders.
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.